Lanmar

This Biotech stock is likely to be a HUGE winner this year

看多
Lanmar 已更新   
NASDAQ:BIOS   None
A minimum expected target is 60% ROI ($6 per share). A multi-bagger is definitely in the cards as it historically returned several x from its previous bottoms in 2000 and 2008/2009.
評論:
Bullish structure still intact ... earnings release in two days. Technical structure continues to suggest major upside is more likely.

評論:
Major rally since yesterday

評論:
Massive failed breakout. I got lucky to get out at a small lose just under my average cost of 3.25. Situations like these should constantly remind us why risk management is so crucial to success as a trader.
交易結束:達到停損點:
loss*
交易進行:
Re-entered at 3.85 and added at 4.15. The key with this trade from here is it coming to fruition quickly.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。